Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Dicker

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Haematologica|June 27, 2012
Use of CBL exon 8 and 9 mutations in diagnosis of myeloproliferative neoplasms and myelodysplastic/myeloproliferative disorders: an analysis of 636 casesSusanne Schnittger, Ulrike Bacher, Tamara Alpermann, et al.
Clinical Toxicology (Philadelphia, Pa.)|April 20, 2026
Methotrexate toxicity in the setting of oral therapeutic errors: a multicenter retrospective studyMichael Moss, David B Liss, Andrew J Chambers, et al.
Haematologica|October 17, 2015
Molecular subtypes of NPM1 mutations have different clinical profiles, specific patterns of accompanying molecular mutations and varying outcomes in intermediate risk acute myeloid leukemiaTamara Alpermann, Susanne Schnittger, Christiane Eder, et al.
Blood Cancer Journal|March 3, 2025
Myeloid neoplasms with MYC-positive double minutes: towards recognition as a distinct entityIsolde Summerer, Wencke Walter, Manja Meggendorfer, et al.
Hemasphere|April 23, 2024
Proximally biased V(D)J recombination in the clonal evolution of IGH alleles in <i>KMT2A::AFF1</i> BCP-ALL of all age classesHeiko Müller, Frank Dicker, Constance Bär, et al.
Blood|August 25, 2012
SRSF2 mutations in 275 cases with chronic myelomonocytic leukemia (CMML)Manja Meggendorfer, Andreas Roller, Torsten Haferlach, et al.
Blood|August 24, 2012
A novel hierarchical prognostic model of AML solely based on molecular mutationsVera Grossmann, Susanne Schnittger, Alexander Kohlmann, et al.
The American Journal of Emergency Medicine|December 27, 2024
Tramadol as a fentanyl adulterant: Prevalence and management in a ToxIC Fentalog study prospective cohortFrank Dicker, Emilie Lothet, Evan Schwarz, et al.
Annals of Hematology|December 12, 2018
International external quality assurance of JAK2 V617F quantificationJulia Asp, Vibe Skov, Beatriz Bellosillo, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Haematologica|June 27, 2012
Use of CBL exon 8 and 9 mutations in diagnosis of myeloproliferative neoplasms and myelodysplastic/myeloproliferative disorders: an analysis of 636 casesSusanne Schnittger, Ulrike Bacher, Tamara Alpermann, et al.
Clinical Toxicology (Philadelphia, Pa.)|April 20, 2026
Methotrexate toxicity in the setting of oral therapeutic errors: a multicenter retrospective studyMichael Moss, David B Liss, Andrew J Chambers, et al.
Haematologica|October 17, 2015
Molecular subtypes of NPM1 mutations have different clinical profiles, specific patterns of accompanying molecular mutations and varying outcomes in intermediate risk acute myeloid leukemiaTamara Alpermann, Susanne Schnittger, Christiane Eder, et al.
Blood Cancer Journal|March 3, 2025
Myeloid neoplasms with MYC-positive double minutes: towards recognition as a distinct entityIsolde Summerer, Wencke Walter, Manja Meggendorfer, et al.
Hemasphere|April 23, 2024
Proximally biased V(D)J recombination in the clonal evolution of IGH alleles in <i>KMT2A::AFF1</i> BCP-ALL of all age classesHeiko Müller, Frank Dicker, Constance Bär, et al.
Blood|August 25, 2012
SRSF2 mutations in 275 cases with chronic myelomonocytic leukemia (CMML)Manja Meggendorfer, Andreas Roller, Torsten Haferlach, et al.
Blood|August 24, 2012
A novel hierarchical prognostic model of AML solely based on molecular mutationsVera Grossmann, Susanne Schnittger, Alexander Kohlmann, et al.
The American Journal of Emergency Medicine|December 27, 2024
Tramadol as a fentanyl adulterant: Prevalence and management in a ToxIC Fentalog study prospective cohortFrank Dicker, Emilie Lothet, Evan Schwarz, et al.
Annals of Hematology|December 12, 2018
International external quality assurance of JAK2 V617F quantificationJulia Asp, Vibe Skov, Beatriz Bellosillo, et al.
Pageof 5